PubRank

Itaru Matsumura

Author PubWeight™ 42.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 2002 2.20
2 Roles for c-Myc in self-renewal of hematopoietic stem cells. J Biol Chem 2004 1.95
3 Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines. Br J Haematol 2004 1.70
4 Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood 2002 1.68
5 The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 2013 1.58
6 Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration. Blood 2002 1.18
7 Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J Exp Med 2004 1.17
8 Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem 2004 1.15
9 GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood 2002 1.15
10 Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol Endocrinol 2002 1.09
11 Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells. J Biol Chem 2002 1.04
12 Cell cycle regulation in hematopoietic stem/progenitor cells. Cell Cycle 2004 1.02
13 Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts. J Biol Chem 2003 0.99
14 Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes 2002 0.98
15 AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells. J Biol Chem 2008 0.97
16 Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes. Int J Hematol 2008 0.96
17 NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells. Biochem Biophys Res Commun 2012 0.95
18 GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J Biol Chem 2005 0.92
19 NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J Biol Chem 2004 0.92
20 Increased natural killer cells and decreased CD3(+)CD8(+)CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib. Br J Haematol 2011 0.92
21 PICOT is a molecule which binds to anamorsin. Biochem Biophys Res Commun 2011 0.90
22 Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy. J Am Acad Dermatol 2009 0.89
23 The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in mice. PLoS One 2012 0.88
24 Opposing effects of PML and PML/RAR alpha on STAT3 activity. Blood 2002 0.87
25 FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells. J Biol Chem 2009 0.86
26 Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant. Oncogene 2005 0.84
27 Antifungal activity of micafungin in serum. Antimicrob Agents Chemother 2009 0.83
28 Necessity of tyrosine 719 and phosphatidylinositol 3'-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation. Blood 2002 0.83
29 Signaling through the interleukin-18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury. Kidney Int 2012 0.82
30 BCR-ABL but not JAK2 V617F inhibits erythropoiesis through the Ras signal by inducing p21CIP1/WAF1. J Biol Chem 2010 0.81
31 Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents. Int J Hematol 2014 0.81
32 Frequency of intravascular large B-cell lymphoma in Japan: study of the Osaka Lymphoma Study Group. J Hematol Oncol 2011 0.80
33 Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296. Int J Hematol 2002 0.80
34 Diffuse large B cell lymphoma with an interfollicular pattern of proliferation shows a favourable prognosis: a study of the Osaka Lymphoma Study Group. Histopathology 2012 0.80
35 HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells. Stem Cells 2006 0.80
36 Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells. Int J Hematol 2003 0.79
37 A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: correlation of quantitation with major BCR-ABL mRNA kits. Int J Hematol 2015 0.79
38 Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma. Int J Hematol 2014 0.77
39 The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients. Leuk Lymphoma 2008 0.77
40 Effects of tamibarotene for the treatment of adult T cell leukemia. Ann Hematol 2011 0.77
41 Loss of genomic DNA copy numbers in the p18, p16, p27 and RB loci in blastic plasmacytoid dendritic cell neoplasm. Eur J Dermatol 2012 0.77
42 Cellulitis with leukocytopenia as an initial sign of acute promyelocytic leukemia. Case Rep Dermatol 2012 0.77
43 Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation. Leuk Res 2011 0.76
44 Senescence induction therapy for the treatment of adult T-cell leukemia. Leuk Lymphoma 2010 0.75
45 [Molecular mechanisms in the resistance of CML stem cells to tyrosine kinase inhibitors and novel targets for achieving a cure]. Rinsho Ketsueki 2015 0.75
46 [Positioning of autoPBSCT in the treatment of multiple myeloma in the era of new drugs]. Nihon Rinsho 2015 0.75
47 Superimposed linear graft-versus-host disease and secondary cutaneous involvement of anaplastic large cell lymphoma. Eur J Dermatol 2011 0.75
48 [Relationship between red blood cell transfusion volume and posttransfusional iron overload in hematological diseases]. Rinsho Ketsueki 2013 0.75
49 [The 2nd generation of TKIs for chronic myeloid leukemia]. Rinsho Ketsueki 2010 0.75
50 Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide. Int J Hematol 2011 0.75
51 [Molecular target therapy for myelodysplastic syndrome]. Nihon Rinsho 2012 0.75
52 [Roles of the 2nd generation TKIs for CML]. Rinsho Ketsueki 2011 0.75
53 Cryoglobulinaemia (IgG-κ-type and IgM-γ-type) with Occluding Leukocytoclastic Vasculitis in a Patient with Vitiligo and Demyelinating Polyneuropathy. Acta Derm Venereol 2016 0.75
54 Second primary malignancies among patients with myeloma-related-diseases in the KMF database. Rinsho Ketsueki 2016 0.75
55 [Pathogenesis and pathophysiology of chronic myeloid leukemia in chronic phase]. Nihon Rinsho 2012 0.75
56 Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma. Leuk Lymphoma 2013 0.75
57 Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). Intern Med 2012 0.75
58 [Standard therapies for acute myeloid leukemia]. Rinsho Ketsueki 2009 0.75
59 Antitumor necrosis factor alpha inhibitor-induced dermatomyositis and interstitial lung disease with anti-PL12 autoantibody: signs of antisynthetase syndrome. J Dermatol 2014 0.75
60 Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era. Int J Hematol 2013 0.75
61 Azacitidine therapy for low-risk myelodysplastic syndrome developing after solid organ transplantation. Rinsho Ketsueki 2017 0.75
62 Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells. Immunol Lett 2011 0.75
63 Two consecutive pregnancies in a patient with paroxysmal nocturnal haemoglobinuria treated with anticoagulant therapy at different doses. Blood Coagul Fibrinolysis 2016 0.75
64 [Treatment of chronic myeloid leukemia in chronic phase]. Rinsho Ketsueki 2014 0.75
65 Successful allogeneic hematopoietic stem cell transplantation in a young patient with Richter syndrome presenting with chronic lymphocytic leukemia and diffuse large B-cell lymphoma with different cell origins. Intern Med 2013 0.75
66 [Inhibition of leukemogenic signaling and its therapeutic implications]. Rinsho Ketsueki 2002 0.75
67 [Molecular targeting therapy of hematopoietic tumors]. Nihon Naika Gakkai Zasshi 2006 0.75
68 [Treatment for de novo chronic myeloid leukemia in chronic phase]. Nihon Rinsho 2012 0.75
69 Localised giant haematoma and subsequent widespread purpura as a sign of acquired haemophilia A. Australas J Dermatol 2012 0.75
70 Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection. Hematology 2012 0.75
71 [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 6. Current treatment strategies for chronic myelogenous leukemia]. Nihon Naika Gakkai Zasshi 2014 0.75
72 Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia. J Clin Immunol 2015 0.75
73 HIV-negative Primary Bone Marrow Hodgkin Lymphoma Manifesting with a High Fever Associated with Hemophagocytosis as the Initial Symptom: A Case Report and Review of the Previous Literature. Intern Med 2015 0.75
74 [Immune evasion of Pseudomonas aeruginosa]. Nihon Rinsho Meneki Gakkai Kaishi 2014 0.75
75 Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis. J Clin Exp Hematop 2016 0.75
76 A case of chronic myelomonocytic leukemia who developed pericardial effusion during stably controlled leukocytosis. Intern Med 2011 0.75